
    
      A breast MRI will be performed in the standard way for diagnosis and to serve as a baseline.
      A second MRI will be performed within a month and following administration of letrozole 12.5
      mg daily for three days to reduce breast estrogen levels and in anticipation of lowering
      breast gadolinium dye uptake.
    
  